Teva Pharmaceutical Q3 2024 Earnings Preview
by
Contributor since / Followers
Contributor since / Followers
16 hours ago
- Teva Pharmaceutical (NYSE:TEVA) is scheduled to announce Q3 earnings results on Wednesday, November 6th, before market open.
- The consensus EPS Estimate is $0.66 (+10.0% Y/Y) and the consensus Revenue Estimate is $4.13B (+5.9% Y/Y).
- Over the last 2 years, TEVA has beaten EPS estimates 38% of the time and has beaten revenue estimates 75% of the time.
- Over the last 3 months, EPS estimates have seen 4 upward revisions and 0 downward. Revenue estimates have seen 2 upward revisions and 1 downward.